Extracellular vesicles and COPD: foe or friend?

Area of Science:

• Pulmonology
• Cell Biology
• Biochemistry

Background:

• Chronic obstructive pulmonary disease (COPD) is a progressive inflammatory airway disease with complex underlying biological mechanisms.
• Extracellular vesicles (EVs), including exosomes and microvesicles, are key mediators of intercellular communication, carrying bioactive molecules.
• EVs are found in various bodily fluids, suggesting their potential involvement in systemic disease processes like COPD.

Purpose of the Study:

• To elucidate the role of EVs from diverse cellular origins in the pathogenesis of COPD.
• To explore the potential of EVs as diagnostic biomarkers for COPD and its exacerbations.
• To review the therapeutic applications of EVs in COPD treatment and future prospects.

Main Methods:

• Literature review and synthesis of current research on EVs in COPD.
• Analysis of the molecular cargo within EVs and their impact on COPD pathophysiology.
• Evaluation of diagnostic potential and therapeutic strategies involving EVs for COPD.

Main Results:

• EVs contribute significantly to COPD pathogenesis through mechanisms like protein hydrolysis, inflammation, and altered cellular functions.
• EVs derived from different cell types exhibit distinct roles in COPD development and progression.
• EVs show potential as non-invasive biomarkers for COPD diagnosis and monitoring acute exacerbations.

Conclusions:

• EVs are integral to COPD pathogenesis and progression, acting as critical mediators of intercellular communication.
• EVs hold significant promise as diagnostic biomarkers for COPD, enabling earlier and more accurate detection.
• EV-based therapeutic strategies, including their use as drug delivery systems, represent a promising frontier for COPD treatment.